Groups
Conceicao C, Thakur N, Human S, Kelly J T, Logan L, Bialy D, Bhat S, Stevenson-Leggett P, Zagrajek A K, Hollinghurst P, Varga M, Tsirigoti C, Hammond J A, Maier H J, Bickerton E, Shelton H, Dietrich I, Graham S C, Bailey D
(2020)
The SARS-CoV-2 Spike protein has a broad tropism 1 for mammalian ACE2 proteins
PLOS Biology 18 (12) , e3001016
Publisher’s version: https://doi.org/10.1371/journal.pbio.3001016
Holzer B, Rijal P, McNee A, Paudyal B, Clark B, Manjegowda T, Salguero F J, Bessell E, Schwartz J C, Moffat K, Pedrera M, Graham S P, Placido M B-D, La Ragione R M, Mwangi W, Beverley P, McCauley J W, Daniels R S, Hammond J, Townsend A R, Tchilian E
(2020)
Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans
bioRxiv preprint , 2020.07.21.213470
Publisher’s version: https://doi.org/10.1101/2020.07.21.213470
Rathakrishnan A, Moffat K, Reis A L, Dixon L K
(2020)
Production of recombinant African swine fever viruses: speeding up the process
Viruses 12 (6)
Publisher’s version: https://doi.org/10.3390/v12060615
Tan T K, Rijal P, Rahikainen R, Keeble A H, Schimanski L, Hussain S, Harvey R, Hayes J W P, Edwards J C, McLean R K, Martini V, Pedrera M, Thakur N, Conceicao C, Dietrich I, Shelton H, Ludi A, Wilsden G, Browning C, Zagrajek A K, Bialy D, Bhat S, Stevenson-Leggett P, Hollinghurst P, Tully M, Moffat K, Chiu C, Waters R, Gray A, Azhar M, Mioulet V, Newman J, Asfor A S, Burman A, Crossley S, Hammond J A, Tchilian E, Charleston B, Bailey D, Tuthill T J, Graham S P, Malinauskas T, Huo J, Tree J A, Buttigieg K R, Owens R J, Caroll M W, Daniels R S, McCauley J W, Huang K-Y A, et al
(2020)
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
bioRxiv preprint
Publisher’s version: https://doi.org/10.1101/2020.08.31.275701
Tang N, Zhang Y, Sadigh Y, Moffat K, Shen Z, Nair V, Yao Y
(2020)
Generation of a triple insert live avian herpesvirus vectored vaccine using CRISPR/Cas9-based gene editing
Vaccines 8 (1) , 97
Publisher’s version: https://doi.org/10.3390/vaccines8010097